Archives

Women In Bio Names Selexis Director of Business Development and Licensing Jessica Bosc as President

Meet with Selexis Scientific and Business Leaders at Upcoming Industry Conferences

Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer

Teneobio and Selexis Expand Relationship with Three Commercial License Agreements for Multi-specific Antibody Candidates in Oncology

Generium Launches First Biosimilar of Dornase Alfa; Becomes Sixth Approved Product Using Selexis SUREtechnology Platform